AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $307B
1-Year Return 24.17%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Quarter Return
-6.77%
1 Year Return
+24.17%
3 Year Return
+108.02%
5 Year Return
+184.14%
10 Year Return
+481.49%
AUM
$259B
AUM Growth
-$23.7B
Cap. Flow
+$1.57B
Cap. Flow %
0.61%
Top 10 Hldgs %
24.79%
Holding
3,384
New
99
Increased
1,504
Reduced
1,399
Closed
133

Sector Composition

1 Technology 26.03%
2 Healthcare 16.1%
3 Consumer Discretionary 12.27%
4 Financials 11.96%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TME icon
3151
Tencent Music
TME
$37.7B
$59K ﹤0.01%
+12,095
New +$59K
NAGE
3152
Niagen Bioscience, Inc. Common Stock
NAGE
$750M
$59K ﹤0.01%
24,100
-5,200
-18% -$12.7K
NGD
3153
New Gold Inc
NGD
$4.99B
$57K ﹤0.01%
31,671
+9,571
+43% +$17.2K
ZVRA icon
3154
Zevra Therapeutics
ZVRA
$502M
$57K ﹤0.01%
11,400
SLDB icon
3155
Solid Biosciences
SLDB
$428M
$56K ﹤0.01%
3,113
-767
-20% -$13.8K
OLMA icon
3156
Olema Pharmaceuticals
OLMA
$570M
$53K ﹤0.01%
12,400
-3,300
-21% -$14.1K
FSM icon
3157
Fortuna Silver Mines
FSM
$2.35B
$52K ﹤0.01%
+13,566
New +$52K
AXDX
3158
DELISTED
Accelerate Diagnostics
AXDX
$51K ﹤0.01%
3,541
+10
+0.3% +$144
QTNT
3159
DELISTED
Quotient Limited Ordinary Shares
QTNT
$51K ﹤0.01%
1,053
-5,839
-85% -$283K
SYRE icon
3160
Spyre Therapeutics
SYRE
$1.03B
$50K ﹤0.01%
864
-160
-16% -$9.26K
PASG icon
3161
Passage Bio
PASG
$22.8M
$49K ﹤0.01%
785
ETNB icon
3162
89bio
ETNB
$1.32B
$48K ﹤0.01%
12,700
-1,300
-9% -$4.91K
ADTHW
3163
DELISTED
AdTheorent Holding Company, Inc. Warrants
ADTHW
$48K ﹤0.01%
33,933
CCV.WS
3164
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$48K ﹤0.01%
77,876
ICAD
3165
DELISTED
iCAD Inc
ICAD
$46K ﹤0.01%
10,400
-1,900
-15% -$8.4K
FSSIW
3166
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
$46K ﹤0.01%
146,570
FSRDW
3167
DELISTED
Fast Radius, Inc. Warrants
FSRDW
$46K ﹤0.01%
288,264
MBIO icon
3168
Mustang Bio
MBIO
$10.4M
$44K ﹤0.01%
58
-13
-18% -$9.86K
ABUS icon
3169
Arbutus Biopharma
ABUS
$805M
$42K ﹤0.01%
14,100
LCTX icon
3170
Lineage Cell Therapeutics
LCTX
$279M
$42K ﹤0.01%
27,500
-6,300
-19% -$9.62K
NGNE icon
3171
Neurogene
NGNE
$285M
$42K ﹤0.01%
1,125
-130
-10% -$4.85K
ZY
3172
DELISTED
Zymergen Inc. Common Stock
ZY
$42K ﹤0.01%
14,702
BOAC.WS
3173
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$42K ﹤0.01%
123,645
FBIO icon
3174
Fortress Biotech
FBIO
$110M
$41K ﹤0.01%
2,013
-327
-14% -$6.66K
KRE icon
3175
SPDR S&P Regional Banking ETF
KRE
$3.99B
$41K ﹤0.01%
+590
New +$41K